Trial Profile
A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 28 Dec 2018
Price :
$35
*
At a glance
- Drugs Subutinib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Chia Tai Tianqing Pharmaceutical Group
- 16 Mar 2013 New trial record